Table 1.
Clinical characteristics of the study population
| Patient Characteristics | All | Diabetics | Non-Diabetics |
|---|---|---|---|
| (mean ± SEM) | (mean ± SEM) | (mean ± SEM) | |
| Age, (years) | 61.32 ± 1.08 | 62.27 ± 1.23 | 60.11 ± 1.89 |
| BMI, (kg/m2) | 34.914 ± 1.01 | 38.31 ± 1.27 | 30.55 ± 1.29 **** |
| HbA1c, (mmol/mol) | 56.80 ± 2.16 | 65.07 ± 2.41 | 40.26 ± 0.73 **** |
| HbA1C, (%) | 7.143 ± 0.18 | 8.14 ± 0.23 | 5.87 ± 0.05 **** |
| Glucose Serum, (mg/dl) | 123.375 ± 6.66 | 143.84 ± 10.71 | 97.06 ± 2.96 *** |
| Total Cholesterol, (mg/dl) | 179.25 ± 4.10 | 175.33 ± 5.05 | 184.29 ± 6.76 |
| Cholesterol HDL, (mg/dl) | 58.45 ± 2.32 | 53.31 ± 1.96 | 65.06 ± 4.46 * |
| Cholesterol LDL, (mg/dl) | 101.34 ± 3.43 | 98.76 ± 4.29 | 104.66 ± 5.58 |
| Cholesterol VLDL, (mg/dl) | 19.46 ± 1.24 | 23.27 ± 1.89 | 14.57 ± 0.94 *** |
| Triglycerides, (mmol/l) | 97.11 ± 6.15 | 115.93 ± 9.45 | 72.91 ± 4.68 ** |
| Creatinine, (mg/dl) | 0.87 ± 0.02 | 0.90 ± 0.03 | 0.83 ± 0.03 |
| BUN/ Creatinine, Ratio | 16.65 ± 0.54 | 17.24 ± 0.75 | 15.89 ± 0.74 |
| Sodium (Na+), (mmol/l) | 140.49 ± 0.29 | 140.11 ± 0.42 | 140.97 ± 0.37 |
| Calcium (Ca2+), (mg/dl) | 9.51 ± 0.05 | 9.49 ± 0.67 | 9.53 ± 0.08 |
| Potassium, (mmol/l) | 4.19 ± 0.04 | 4.23 ± 0.06 | 4.15 ± 0.06 |
| MIR17, (∆CT) | 1.33 ± 0.06 | 1.65 ± 0.20 | 0.92 ± 0.26 * |
*significant at p < 0.05; **significant at p < 0.005;
***significant at p < 0.001; ****significant at p < 0.0001